Awilco Drilling Plc
9.2.2021 12:38:40 CET | Globenewswire | Press release
Awilco Drilling PLC’s Fourth Quarter 2020 report will be released prior to market opening on Wednesday 10 February 2021. A digital presentation will be held on 10 February 2021 at 13:00 UK time (14:00pm CET / 08:00 EST). The presentation will be available for download on the Investor Relations section (go to "Press Releases") at www.awilcodrilling.com prior to the meeting. There will be a Q&A session after the presentation.
To join the digital meeting, please click this link or copy and paste the following address into your browser:
https://teams.microsoft.com/l/meetup-join/19%3ameeting_ZDU1M2ZkMzYtNjQwNi00NTU1LTg5OTctM2IzMjUxMmY3Y2Iy%40thread.v2/0?context=%7b%22Tid%22%3a%22c6903860-15d6-4675-a5fe-cf03764de020%22%2c%22Oid%22%3a%22b70a3a9b-a081-41f9-b2a4-3e57ef82979e%22%2c%22IsBroadcastMeeting%22%3atrue%7d
A replay of the presentation will be made available on the Company website after the event.
Aberdeen, 9 February 2021
For further information please contact:
Eric Jacobs, Interim CEO
Phone: +44 1224 737900
Cathrine Haavind, IR Manager
Phone: +47 93 42 84 64
Email: ch@awilcodrilling.com
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
King Faisal Specialist Hospital & Research Centre13.3.2026 22:15:53 CET | Press release
KFSH Leads Globally in Paired Kidney Transplants Performed at a Single Center in 2025
SCOR13.3.2026 18:59:39 CET | Press release
SCOR SE announces the availability of its 2025 Universal Registration Document
Novartis Pharma AG13.3.2026 18:35:19 CET | Press release
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
Luotea Oyj13.3.2026 18:30:00 CET | Press release
The Board of Directors of Luotea Oyj decided on updates to the company's share-based incentive plan for 2023-2027 and on the launch of a new share-based incentive plan for the years 2026-2030
Ilkka Oyj13.3.2026 18:00:00 CET | Press release
Ilkka Oyj: Acquisition of own shares on 13 March 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
